Product Information
NORTRIPTYLINE HCL 25 MG CAP is a generic product labeled by Taro Pharmaceuticals U.S.A. Inc., priced at $0.1578 per EA under NDC 51672400202. Its NADAC has been published 629 times since Feb 5, 2014.
FDA first approved this application on May 8, 2000. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
Taro Pharmaceuticals U.S.A. Inc.NDC
51672400202
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
NORTRIPTYLINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA075520FDA Approved
5/8/2000
TE Code
AB
On Market Since
5/8/2000
Pharmacological Classes
Price Statistics
The NADAC for NORTRIPTYLINE HCL 25 MG CAP has been published 629 times since Feb 5, 2014, and over the history we have for it it has risen 12.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1578 per EA |
|---|---|
| All-time high | $0.1710 (Sep 10, 2025) |
| All-time low | $0.0732 (May 22, 2024) |
| 52-week high | $0.1710 |
| 52-week low | $0.1578 |
| Median price | $0.1150 |
| Average price | $0.1173 |
| Largest weekly change | +23.5% (Aug 21, 2024) |
| Weeks tracked | 629 |
| Tracking since | Feb 5, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-7.7%
3Y
+91.1%
5Y
+48.1%
All
+12.8%
Last surveyed Feb 18, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 34% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of NORTRIPTYLINE HCL 25 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for NORTRIPTYLINE HCL 25 MG CAP, manufactured by Taro Pharmaceuticals U.S.A. Inc., is $0.1578 per EA (NDC 51672400202), effective Feb 18, 2026.
How has the price of NORTRIPTYLINE HCL 25 MG CAP changed over time?
Over the history we have for it, the NADAC for NORTRIPTYLINE HCL 25 MG CAP has risen 12.8%. It has been tracked across 629 weekly CMS publications since Feb 5, 2014.
What are the highest and lowest recorded NADAC prices for NORTRIPTYLINE HCL 25 MG CAP?
Since Feb 5, 2014, the NADAC for NORTRIPTYLINE HCL 25 MG CAP has ranged from a low of $0.0732 (May 22, 2024) to a high of $0.1710 (Sep 10, 2025), with a median of $0.1150 per EA.
Are there cheaper alternatives to NORTRIPTYLINE HCL 25 MG CAP?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NORTRIPTYLINE HCL 25 MG CAP, is $0.1047 per EA — about 34% below NORTRIPTYLINE HCL 25 MG CAP.
Who manufactures NORTRIPTYLINE HCL 25 MG CAP?
NORTRIPTYLINE HCL 25 MG CAP (NDC 51672400202) is labeled by Taro Pharmaceuticals U.S.A. Inc., and CMS classifies it as a generic product.